Alumni Symposium Honoring Dan Littman - June 27, 2017

Date: 
Wed, 06/07/2017 - 4:00am

Session I: Immune Cell Development and Function

Chair: Maria Pokrovskii

9:00–9:20

Mark Chong, PhD

St. Vincent’s Institute of Medical Research, Melbourne, Australia

MicroRNA-independent regulation of HSC function by Drosha

9:20–9:40

Yong-Rui Zou, PhD

Feinstein Institute for Medical Research, Manhasset, NY

Niche and immune responses

9:40–10:00

Liang Zhou, MD, PhD

University of Florida, Gainesville

On the journey to understanding Ahr

10:00–10:20

Wilfried Ellmeier, PhD

Medical University of Vienna, Austria

Transcriptional control of          T cell development and function

10:20–10:40

Ichiro Taniuchi, MD, PhD

RIKEN Research Center for Allergy and Immunology, Yokohama, Japan

Runx transcriptional factors and immune cell development

10:40–11:00

HongKui Deng, PhD

Center for Life Sciences, Peking University, Beijing, China

Reprogramming cell fate by small molecules

11:00–11:30

Break

Session II: Intestinal Immunity and Microbiota • Th17

Chair: Hannah Fehlner-Peach

11:30–11:50

Randy Longman, MD, PhD

Weill Cornell Medicine, New York, NY

The mucosal and systemic impact of the Littman lab microbiome

11:50–12:10

Ivo Ivanov, PhD

Columbia University, New York, NY

Interactions at the wall

12:10–12:30

Zuoming Sun, PhD

City of Hope, Duarte, CA

SRC1 function in reciprocal Th17 and Treg differentiation

12:30–12:50

Jun Huh, PhD

University of Massachusetts Medical School, Worcester

Gut bacteria, inflammation and neurodevelopmental disorder

12:50–1:10

Derya Unutmaz, MD

The Jackson Laboratory, Farmington, CT

Awakening the force in human T cells

1:10–2:10

Lunch

Session III: Recent Advances in HIV Research

Chair: Charles Ng

2:10–2:30

Richard Sutton, MD, PhD

Yale School of Medicine, New Haven, CT

R5 virus resistance observed in a subset of HIV+ Elite Controllers

2:30–2:50

Nicolas Manel, PhD

Institut Curie, Paris, France

Start making sense! Identification of an HIV capsid sensor

2:50–3:10

Ned Landau, PhD

NYU School of Medicine, New York, NY

HIV host dependency and restriction factors

3:10–3:30

Doug Kwon, MD, PhD

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA

The cervicovaginal microbiome, genital inflammation, and HIV acquisition in African women

3:30–3:50

Vineet KewalRamani, PhD

National Cancer Institute, NIH, Frederick, MD

HIV-1 exploitation of nuclear speckles to access gene-rich regions of chromatin

3:50–4:10

Break

Session IV: Myeloid Cells • Cancer Therapy

Chair: Jason Hall, PhD

4:10–4:30

Gretchen Diehl, PhD

Baylor College of Medicine, Houston, TX

Microbes calm immunity

4:30–4:50

Steffen Jung, PhD

Weizmann Institute of Science, Rehovot, Israel

News from the goldmine

4:50–5:10

Takeshi Egawa, MD, PhD

Washington University in St. Louis, MO

CD4 silencing to tumor suppression

5:10–5:30

Isabelle Rivière, PhD

Memorial Sloan Kettering Cancer Center, New York, NY

CAR Therapy: The CD19 paradigm and beyond

5:30–5:50

Frédéric Geissmann, MD, PhD

Memorial Sloan Kettering Cancer Center, New York, NY

Somatic mosaicism in the myeloid system: tumoral and degenerative diseases